BEAM vs MS · rev $63.5M vs P/E 20, $344.27B cap
Beam Therapeutics Inc (BEAM) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
MS does not have a complete income-statement cache yet.
BEAM currently screens at market cap $2.01B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the BEAM and MS stock pages for the full models.
Not investment advice.